AstraZeneca investors baulk at $400 billion Bristol Myers talks - reuters.com
- AstraZeneca investors baulk at $400 billion Bristol Myers talks reuters.com
- AstraZeneca slides after report of Bristol Myers merger talks leaves analysts 'perplexed' CNBC
- Bristol Myers Squibb Stock Soars on Report of $400 Billion Merger Talks With AstraZeneca Barron's
- Editor’s Corner: Why an AstraZeneca-Bristol Myers Squibb merger is a bad idea Fierce Pharma
- Biotech Stocks Need A Shot In The Arm After Brutal July: Could AstraZeneca-Bristol Myers Megadeal Be The Cure? Yahoo Finance
Related Markets
All MarketsMarket data may be delayed. Not financial advice.
💡 AI analysis provides alternative perspectives on current events